Literature DB >> 698027

Catecholamine sensitivity in hyperthyroidism and hypothyroidism.

D G McDevitt, J G Riddell, D R Hadden, D A Montgomery.   

Abstract

1. Catecholamine sensitivity in hyper- and hypothyroidism has been studied using a standardised isoprenaline sensitivity test. 2. Seven patients with hyperthyroidism and seven with hypothyroidism were tested both when showing evidence of thyroid dysfunction and again when euthyroid. 3. No significant differences were seen in heart rate responses to isoprenaline when patients became euthyroid compared to their response when either hyperthyroid or hypothyroid. 4. These results indicate that sensitivity to catecholamines is not altered in thyroid dysfunction and, in particular, that hypersensitivity does not occur in spontaneous hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 698027      PMCID: PMC1429479          DOI: 10.1111/j.1365-2125.1978.tb00855.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  W E Dixon Memorial Lecture. Beta-adrenoceptor blockade in hyperthyroidism and anxiety.

Authors:  P Turner
Journal:  Proc R Soc Med       Date:  1976-05

Review 2.  ADRENAL MEDULLARY AND THYROID RELATIONSHIPS.

Authors:  T S HARRISON
Journal:  Physiol Rev       Date:  1964-04       Impact factor: 37.312

3.  THE EFFECT OF THYROXIN, CORTICOSTEROIDS, AND EPINEPHRINE ON ATRIAL RATE.

Authors:  G M CRAVEY; J S GRAVENSTEIN
Journal:  J Pharmacol Exp Ther       Date:  1965-04       Impact factor: 4.030

4.  Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism.

Authors:  W R Wilson; E O Theilen; J H Hege; M R Valenca
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

Review 5.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Intravenously administered isoproterenol sulfate dose-response curves in man.

Authors:  C F George; M E Conolly; T Fenyvesi; R Briant; C T Dollery
Journal:  Arch Intern Med       Date:  1972-09

7.  Studies of the reputed augmentation of the cardiovascular effects of catecholamines in patients with spontaneous hyperthyroidism.

Authors:  V S Aoki; W R Wilson; E O Theilen
Journal:  J Pharmacol Exp Ther       Date:  1972-05       Impact factor: 4.030

8.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

9.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Assessment of selective beta-adrenoceptor blockade in man.

Authors:  R H Briant; C T Dollery; T Fenyvesi; C F George
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

View more
  10 in total

1.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

Review 2.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Quantitative changes in beta-adrenergic responses of isolated atria from hyper- and hypothyroid rats.

Authors:  H P Rub; H Thommen; H Porzig
Journal:  Experientia       Date:  1981-04-15

5.  Thyroid hormone modulates inotropic responses, alpha-adrenoceptor density and catecholamine concentrations in the rat heart.

Authors:  J Zwaveling; H D Batink; J de Jong; E A Winkler Prins; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

6.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Airway response to inhaled salbutamol in hyperthyroid and hypothyroid patients before and after treatment.

Authors:  R N Harrison; A E Tattersfield
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

9.  Short-term variability of blood pressure and heart rate in hyperthyroidism.

Authors:  A Girard; F C Hugues; C Le Jeunne; J L Elghozi
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

10.  Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.

Authors:  K Tawara; K Kawashima; H Ishikawa; K Yamamoto; K Saito; A Ebihara; S Yoshida
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.